Polaris Venture Partners V, L.P. - Insider Trading Tracker

एटिर फार्मा, इंक.

US ˙ NasdaqCM ˙ US0021202025

परिचय

यह पृष्ठ Polaris Venture Partners V, L.P. के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Polaris Venture Partners V, L.P. ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:ADGI / Adagio Therapeutics Inc		3,120,194
US:LYRA / Lyra Therapeutics, Inc.	10% Owner	0
US:PHR / Phreesia, Inc.	10% Owner	31,015
US:CDLX / Cardlytics, Inc.	10% Owner	21,331
US:PULM / Pulmatrix, Inc.	10% Owner	7,700
US:ASNS / Actelis Networks, Inc.	10% Owner	0
US:SELB / Selecta Biosciences Inc	10% Owner	0
US:TTOO / T2 Biosystems, Inc.	10% Owner	2,030,917
US:GNCA / Genocea Biosciences Inc	10% Owner	1,968,606
US:LIFE / aTyr Pharma, Inc.	10% Owner	0
US:OCUL / Ocular Therapeutix, Inc.	10% Owner	19,588
US:TRVN / Trevena, Inc.	10% Owner	36,369
US:CERU / Cerulean Pharma Inc.	10% Owner	25,092
US:FATE / Fate Therapeutics, Inc.	10% Owner	0
US:BIND / BIND Therapeutics, Inc.	10% Owner	0

चार्ट को कैसे समझे

निम्नलिखित चार्ट Polaris Venture Partners V, L.P. द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी ATYR / aTyr Pharma, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम ATYR / aTyr Pharma, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

इनसाइडर बिक्री ATYR / aTyr Pharma, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम ATYR / aTyr Pharma, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CDLX / Cardlytics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री CDLX / Cardlytics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2019-06-07	CDLX	Polaris Venture Management Co. V, L.L.C.	96,493	25.6212	96,493	25.6212	2,472,266	19	23.5400	-200,821	-8.12
2019-06-07	CDLX	Polaris Venture Management Co. V, L.L.C.	1,881	25.6212	1,881	25.6212	48,193
2019-06-07	CDLX	Polaris Venture Management Co. V, L.L.C.	661	25.6212	661	25.6212	16,936
2019-06-07	CDLX	Polaris Venture Management Co. V, L.L.C.	965	25.6212	965	25.6212	24,724
2019-06-06	CDLX	Polaris Venture Management Co. V, L.L.C.	294	25.0000	294	25.0000	7,350
2019-06-06	CDLX	Polaris Venture Management Co. V, L.L.C.	6	25.0000	6	25.0000	150
2019-06-06	CDLX	Polaris Venture Management Co. V, L.L.C.	2	25.0000	2	25.0000	50
2019-06-06	CDLX	Polaris Venture Management Co. V, L.L.C.	3	25.0000	3	25.0000	75
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	3,939	23.6252	3,939	23.6252	93,060
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	32,294	24.9930	32,294	24.9930	807,124
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	1,036	25.3025	1,036	25.3025	26,213
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	80	23.6333	80	23.6333	1,891
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	604	24.9882	604	24.9882	15,093
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	42	25.3017	42	25.3017	1,063
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	30	23.6400	30	23.6400	709
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	211	25.0013	211	25.0013	5,275
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	14	25.2907	14	25.2907	354
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	37	23.6430	37	23.6430	875
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	307	24.9932	307	24.9932	7,673
2019-06-05	CDLX	Polaris Venture Management Co. V, L.L.C.	7	25.3029	7	25.3029	177
2019-06-04	CDLX	Polaris Venture Management Co. V, L.L.C.	35,103	23.2817	35,103	23.2817	817,258
2019-06-04	CDLX	Polaris Venture Management Co. V, L.L.C.	684	23.2817	684	23.2817	15,925
2019-06-04	CDLX	Polaris Venture Management Co. V, L.L.C.	240	23.2817	240	23.2817	5,588
2019-06-04	CDLX	Polaris Venture Management Co. V, L.L.C.	351	23.2817	351	23.2817	8,172
2019-05-28	CDLX	Polaris Venture Management Co. V, L.L.C.	96,493	23.0381	96,493	23.0381	2,223,015
2019-05-28	CDLX	Polaris Venture Management Co. V, L.L.C.	1,881	23.0381	1,881	23.0381	43,335
2019-05-28	CDLX	Polaris Venture Management Co. V, L.L.C.	661	23.0381	661	23.0381	15,228
2019-05-28	CDLX	Polaris Venture Management Co. V, L.L.C.	965	23.0381	965	23.0381	22,232
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	45,743	25.5170	45,743	25.5170	1,167,224
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	2,504	26.4130	2,504	26.4130	66,138
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	891	25.5170	891	25.5170	22,736
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	49	26.4130	49	26.4130	1,294
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	314	25.5170	314	25.5170	8,012
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	17	26.4150	17	26.4150	449
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	456	25.5170	456	25.5170	11,636
2018-09-13	CDLX	Polaris Venture Management Co. V, L.L.C.	26	26.4130	26	26.4130	687
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	75,805	24.6700	75,805	24.6700	1,870,109
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	20,688	25.1880	20,688	25.1880	521,089
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	1,477	24.6690	1,477	24.6690	36,436
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	404	25.1880	404	25.1880	10,176
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	518	24.6690	518	24.6690	12,779
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	143	25.1870	143	25.1870	3,602
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	760	24.6700	760	24.6700	18,749
2018-09-12	CDLX	Polaris Venture Management Co. V, L.L.C.	205	25.1930	205	25.1930	5,165

इनसाइडर खरीदारी DARE / Daré Bioscience, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2014-04-15	CERU	Polaris Venture Management Co. V, L.L.C.	1,470,582	7.0000	1,470,582	7.0000	10,294,074	731

DARE / Daré Bioscience, Inc. Insider Trades

इनसाइडर बिक्री DARE / Daré Bioscience, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी FATE / Fate Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2013-10-04	FATE	Polaris Venture Management Co. V, L.L.C.	804,112	6.0000	804,112	6.0000	4,824,672	173	12.28	5,049,823	104.67
2013-10-04	FATE	Polaris Venture Management Co. V, L.L.C.	15,672	6.0000	15,672	6.0000	94,032
2013-10-04	FATE	Polaris Venture Management Co. V, L.L.C.	5,508	6.0000	5,508	6.0000	33,048
2013-10-04	FATE	Polaris Venture Management Co. V, L.L.C.	8,041	6.0000	8,041	6.0000	48,246

FATE / Fate Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री FATE / Fate Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी GNCAQ / Genocea Biosciences, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2014-02-10	GNCA	Polaris Venture Management Co. V, L.L.C.	232,820	12.0000	29,102	96.0000	2,793,840	130	181.6	2,491,083	89.16

GNCAQ / Genocea Biosciences, Inc. Insider Trades

इनसाइडर बिक्री GNCAQ / Genocea Biosciences, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2015-06-19	GNCA	Polaris Venture Management Co. V, L.L.C.	1,000	13.0000	125	104.0000	13,000	234	21.12	-10,360	-79.69
2015-06-18	GNCA	Polaris Venture Management Co. V, L.L.C.	29,004	13.0400	3,626	104.3200	378,212
2015-06-17	GNCA	Polaris Venture Management Co. V, L.L.C.	10,618	13.0100	1,327	104.0800	138,140
2015-06-16	GNCA	Polaris Venture Management Co. V, L.L.C.	46,000	13.2400	5,750	105.9200	609,040
2014-08-14	GNCA	Polaris Venture Management Co. V, L.L.C.	6,755	13.0100	844	104.0800	87,883
2014-08-13	GNCA	Polaris Venture Management Co. V, L.L.C.	2,905	13.0000	363	104.0000	37,765
2014-08-12	GNCA	Polaris Venture Management Co. V, L.L.C.	20,990	13.0300	2,624	104.2400	273,500
2014-08-11	GNCA	Polaris Venture Management Co. V, L.L.C.	1,428	13.2400	178	105.9200	18,907
2014-08-08	GNCA	Polaris Venture Management Co. V, L.L.C.	41,376	13.4100	5,172	107.2800	554,852

इनसाइडर खरीदारी IVVD / Invivyd, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री IVVD / Invivyd, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी LYRA / Lyra Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	60,308	16.0000	1,206	800.0000	964,928	0	16.65	-944,848	-97.92
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	1,176	16.0000	24	800.0000	18,816
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	603	16.0000	12	800.0000	9,648
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	413	16.0000	8	800.0000	6,608

LYRA / Lyra Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री LYRA / Lyra Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	9,334	16.0000	187	800.0000	149,344	365	8.44	-147,774	-98.95
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	182	16.0000	4	800.0000	2,912
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	94	16.0000	2	800.0000	1,504
2020-05-05	LYRA	Polaris Venture Management Co. V, L.L.C.	64	16.0000	1	800.0000	1,024

इनसाइडर खरीदारी OCUL / Ocular Therapeutix, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

OCUL / Ocular Therapeutix, Inc. Insider Trades

इनसाइडर बिक्री OCUL / Ocular Therapeutix, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2015-02-02	OCUL	Polaris Venture Management Co. V, L.L.C.	482,469	29.5000	482,469	29.5000	14,232,836	351	5.4700	-11,593,730	-81.46
2015-02-02	OCUL	Polaris Venture Management Co. V, L.L.C.	9,403	29.5000	9,403	29.5000	277,388
2015-02-02	OCUL	Polaris Venture Management Co. V, L.L.C.	3,304	29.5000	3,304	29.5000	97,468
2015-02-02	OCUL	Polaris Venture Management Co. V, L.L.C.	4,824	29.5000	4,824	29.5000	142,308

इनसाइडर खरीदारी PHR / Phreesia, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री PHR / Phreesia, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2019-12-17	PHR	Polaris Venture Management Co. V, L.L.C.	344,599	24.4790	344,599	24.4790	8,435,439	92	16.59	-2,718,541	-32.23
2019-12-17	PHR	Polaris Venture Management Co. V, L.L.C.	6,716	24.4790	6,716	24.4790	164,401
2019-12-17	PHR	Polaris Venture Management Co. V, L.L.C.	2,360	24.4790	2,360	24.4790	57,770
2019-12-17	PHR	Polaris Venture Management Co. V, L.L.C.	3,446	24.4790	3,446	24.4790	84,355
2019-07-22	PHR	Polaris Venture Management Co. V, L.L.C.	382,887	18.0000	382,887	18.0000	6,891,966
2019-07-22	PHR	Polaris Venture Management Co. V, L.L.C.	7,462	18.0000	7,462	18.0000	134,316
2019-07-22	PHR	Polaris Venture Management Co. V, L.L.C.	2,622	18.0000	2,622	18.0000	47,196
2019-07-22	PHR	Polaris Venture Management Co. V, L.L.C.	3,828	18.0000	3,828	18.0000	68,904

इनसाइडर खरीदारी PULM / Pulmatrix, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम
2018-04-03	PULM	MCGUIRE TERRANCE	345,551		23,037			69	120
2018-04-03	PULM	MCGUIRE TERRANCE	6,478		432
2018-04-03	PULM	MCGUIRE TERRANCE	769,989		51,333
2018-04-03	PULM	MCGUIRE TERRANCE	15,007		1,000
2018-04-03	PULM	MCGUIRE TERRANCE	5,275		352
2018-04-03	PULM	MCGUIRE TERRANCE	7,700		513
2015-06-15	PULM	MCGUIRE TERRANCE	32,059	6.8750	2,959	74.4792	220,406
2015-06-15	PULM	MCGUIRE TERRANCE	601	6.8750	55	74.4792	4,132
2015-06-15	PULM	MCGUIRE TERRANCE	71,438	6.8750	6,594	74.4792	491,136
2015-06-15	PULM	MCGUIRE TERRANCE	489	6.8750	45	74.4792	3,362
2015-06-15	PULM	MCGUIRE TERRANCE	714	6.8750	66	74.4792	4,909
2015-06-15	PULM	MCGUIRE TERRANCE	1,392	6.8750	128	74.4792	9,570
2015-06-15	PULM	MCGUIRE TERRANCE	71,439	6.8750	6,594	74.4792	491,143
2015-06-15	PULM	MCGUIRE TERRANCE	490	6.8750	45	74.4792	3,369
2015-06-15	PULM	MCGUIRE TERRANCE	715	6.8750	66	74.4792	4,916
2015-06-15	PULM	MCGUIRE TERRANCE	1,392	6.8750	128	74.4792	9,570

इनसाइडर बिक्री PULM / Pulmatrix, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी RNAC / Cartesian Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2016-06-27	SELB	Polaris Venture Management Co. V, L.L.C.	2,821	14.0000	2,821	14.0000	39,494	151	26.3300	34,783	88.07
2016-06-27	SELB	Polaris Venture Management Co. V, L.L.C.	991	14.0000	991	14.0000	13,874
2016-06-27	SELB	Polaris Venture Management Co. V, L.L.C.	1,448	14.0000	1,448	14.0000	20,272
2016-06-27	SELB	Polaris Venture Management Co. V, L.L.C.	144,740	14.0000	144,740	14.0000	2,026,360

RNAC / Cartesian Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री RNAC / Cartesian Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी TRVN / Trevena, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2014-02-05	TRVN	Polaris Venture Management Co. V, L.L.C.	472,405	7.0000	18,896	175.0000	3,306,835	28	241	1,247,101	37.71

इनसाइडर बिक्री TRVN / Trevena, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2014-08-14	TRVN	Polaris Venture Management Co. V, L.L.C.	35,415	6.0400	1,417	151.0000	213,907	116	99.5	-73,014	-34.13
2014-08-14	TRVN	Polaris Venture Management Co. V, L.L.C.	690	6.0400	28	151.0000	4,168
2014-08-14	TRVN	Polaris Venture Management Co. V, L.L.C.	243	6.0400	10	151.0000	1,468
2014-08-14	TRVN	Polaris Venture Management Co. V, L.L.C.	354	6.0400	14	151.0000	2,138
2014-08-13	TRVN	Polaris Venture Management Co. V, L.L.C.	5,500	6.1200	220	153.0000	33,660
2014-08-13	TRVN	Polaris Venture Management Co. V, L.L.C.	107	6.1200	4	153.0000	655
2014-08-13	TRVN	Polaris Venture Management Co. V, L.L.C.	38	6.1200	2	153.0000	233
2014-08-13	TRVN	Polaris Venture Management Co. V, L.L.C.	55	6.1200	2	153.0000	337

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Polaris Venture Partners V, L.P. द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	10b5-1	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2022-03-30		3	ADGI	Adagio Therapeutics, Inc. Common Stock				3,120,194
2022-03-30		3	ADGI	Adagio Therapeutics, Inc. Common Stock				60,814
2022-03-30		3	ADGI	Adagio Therapeutics, Inc. Common Stock				21,374
2022-03-30		3	ADGI	Adagio Therapeutics, Inc. Common Stock				31,198
2022-03-30		3	ADGI	Adagio Therapeutics, Inc. Common Stock				4,800,460
2022-03-30		3	ADGI	Adagio Therapeutics, Inc. Common Stock				497,660
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Warrants	X - Other		-118	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Warrants	X - Other		-173	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Warrants	X - Other		-337	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Warrants	X - Other		-17,304	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion		-13,625	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion		-19,890	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion		-38,765	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion		-1,988,991	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion		-43,966	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion		-64,183	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion		-125,094	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion		-6,418,387	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-4 Convertible Preferred Stock	C - Conversion		-52,700	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-4 Convertible Preferred Stock	C - Conversion		-76,934	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-4 Convertible Preferred Stock	C - Conversion		-149,944	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-4 Convertible Preferred Stock	C - Conversion		-7,693,406	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-58,980	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-86,101	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-167,809	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-3 Convertible Preferred Stock	C - Conversion		-8,610,081	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-22,580	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-32,961	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-64,237	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-3,296,014	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-1/C Convertible Preferred Stock	C - Conversion		-42,941	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-1/C Convertible Preferred Stock	C - Conversion		-62,687	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-1/C Convertible Preferred Stock	C - Conversion		-122,177	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series A-1/C Convertible Preferred Stock	C - Conversion		-6,268,687	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase		413	7,274	6.02	16.00	6,608	116,384
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase		603	10,618	6.02	16.00	9,648	169,888
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase		1,176	20,701	6.02	16.00	18,816	331,216
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase		60,308	1,062,259	6.02	16.00	964,928	16,996,144
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	S - Sale		-64	6,861	-0.92	16.00	-1,024	109,776
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	X - Other		118	6,925	1.73	8.63	1,018	59,763
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	S - Sale		-94	10,015	-0.93	16.00	-1,504	160,240
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	X - Other		173	10,109	1.74	8.63	1,493	87,241
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	S - Sale		-182	19,525	-0.92	16.00	-2,912	312,400
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	X - Other		337	19,707	1.74	8.63	2,908	170,071
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	S - Sale		-9,334	1,001,951	-0.92	16.00	-149,344	16,031,216
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	X - Other		17,304	1,011,285	1.74	8.63	149,334	8,727,390
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion		6,807	6,807
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion		9,936	9,936
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion		19,370	19,370
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion		993,981	993,981
2019-12-18	2019-12-17	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-3,446	31,015	-10.00	24.48	-84,355	759,216
2019-12-18	2019-12-17	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-2,360	21,245	-10.00	24.48	-57,770	520,056
2019-12-18	2019-12-17	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-6,716	60,446	-10.00	24.48	-164,401	1,479,658
2019-12-18	2019-12-17	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-344,599	3,101,386	-10.00	24.48	-8,435,439	75,918,828
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Junior Convertible Preferred Stock	C - Conversion		-84,134	0	-100.00
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Junior Convertible Preferred Stock	C - Conversion		-57,631	0	-100.00
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Junior Convertible Preferred Stock	C - Conversion		-163,973	0	-100.00
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Junior Convertible Preferred Stock	C - Conversion		-8,413,256	0	-100.00
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-3,828	34,461	-10.00	18.00	-68,904	620,298
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-2,622	23,605	-10.00	18.00	-47,196	424,890
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-7,462	67,162	-10.00	18.00	-134,316	1,208,916
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	S - Sale		-382,887	3,445,985	-10.00	18.00	-6,891,966	62,027,730
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	C - Conversion		38,289	38,289
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	C - Conversion		26,227	26,227
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	C - Conversion		74,624	74,624
2019-07-24	2019-07-22	4	PHR	Phreesia, Inc. Common Stock	C - Conversion		3,828,872	3,828,872
2019-07-17	2019-07-17	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-268	21,331	-1.24	27.45	-7,356	585,472
2019-07-17	2019-07-17	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-183	14,595	-1.24	27.45	-5,023	400,589
2019-07-17	2019-07-17	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-552	41,532	-1.31	27.45	-15,151	1,139,929
2019-07-17	2019-07-17	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-26,778	2,131,187	-1.24	27.45	-734,976	58,494,690
2019-07-17	2019-07-16	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-202	21,599	-0.93	27.87	-5,630	601,940
2019-07-17	2019-07-16	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-139	14,778	-0.93	27.87	-3,874	411,847
2019-07-17	2019-07-16	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-394	42,054	-0.93	27.87	-10,980	1,171,999
2019-07-17	2019-07-16	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-20,227	2,157,965	-0.93	27.87	-563,704	60,140,111
2019-07-17	2019-07-15	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-193	21,801	-0.88	27.73	-5,351	604,452
2019-07-17	2019-07-15	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-132	14,917	-0.88	27.73	-3,660	413,587
2019-07-17	2019-07-15	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-376	42,448	-0.88	27.73	-10,425	1,176,909
2019-07-17	2019-07-15	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale	X	-19,283	2,178,192	-0.88	27.73	-534,639	60,392,334
2019-06-11	2019-06-07	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-965	21,994	-4.20	25.62	-24,724	563,513
2019-06-11	2019-06-07	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-661	15,049	-4.21	25.62	-16,936	385,573
2019-06-11	2019-06-07	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-1,881	42,824	-4.21	25.62	-48,193	1,097,202
2019-06-11	2019-06-07	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-96,493	2,197,475	-4.21	25.62	-2,472,266	56,301,946
2019-06-06	2019-06-06	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-3	22,959	-0.01	25.00	-75	573,975
2019-06-06	2019-06-06	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-2	15,710	-0.01	25.00	-50	392,750
2019-06-06	2019-06-06	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-6	44,705	-0.01	25.00	-150	1,117,625
2019-06-06	2019-06-06	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-294	2,293,968	-0.01	25.00	-7,350	57,349,200
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-7	22,962	-0.03	25.30	-177	581,005
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-307	22,969	-1.32	24.99	-7,673	574,069
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-37	23,276	-0.16	23.64	-875	550,314
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-14	15,712	-0.09	25.29	-354	397,367
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-211	15,726	-1.32	25.00	-5,275	393,170
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-30	15,937	-0.19	23.64	-709	376,751
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-42	44,711	-0.09	25.30	-1,063	1,131,264
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-604	44,753	-1.33	24.99	-15,093	1,118,297
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-80	45,357	-0.18	23.63	-1,891	1,071,936
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-1,036	2,294,262	-0.05	25.30	-26,213	58,050,564
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-32,294	2,295,298	-1.39	24.99	-807,124	57,366,383
2019-06-06	2019-06-05	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-3,939	2,327,592	-0.17	23.63	-93,060	54,989,827
2019-06-06	2019-06-04	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-351	23,313	-1.48	23.28	-8,172	542,766
2019-06-06	2019-06-04	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-240	15,967	-1.48	23.28	-5,588	371,739
2019-06-06	2019-06-04	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-684	45,437	-1.48	23.28	-15,925	1,057,851
2019-06-06	2019-06-04	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-35,103	2,331,531	-1.48	23.28	-817,258	54,282,005
2019-05-30	2019-05-28	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-965	23,664	-3.92	23.04	-22,232	545,174
2019-05-30	2019-05-28	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-661	16,207	-3.92	23.04	-15,228	373,378
2019-05-30	2019-05-28	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-1,881	46,121	-3.92	23.04	-43,335	1,062,540
2019-05-30	2019-05-28	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-96,493	2,366,634	-3.92	23.04	-2,223,015	54,522,751
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-26	24,629	-0.11	26.41	-687	650,526
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-456	24,655	-1.82	25.52	-11,636	629,122
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-17	16,868	-0.10	26.42	-449	445,568
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-314	16,885	-1.83	25.52	-8,012	430,855
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-49	48,002	-0.10	26.41	-1,294	1,267,877
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-891	48,051	-1.82	25.52	-22,736	1,226,117
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-2,504	2,463,127	-0.10	26.41	-66,138	65,058,573
2018-09-14	2018-09-13	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-45,743	2,465,631	-1.82	25.52	-1,167,224	62,915,506
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-205	25,111	-0.81	25.19	-5,165	632,621
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-760	25,316	-2.91	24.67	-18,749	624,546
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-143	17,199	-0.82	25.19	-3,602	433,191
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-518	17,342	-2.90	24.67	-12,779	427,810
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-404	48,942	-0.82	25.19	-10,176	1,232,751
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-1,477	49,346	-2.91	24.67	-36,436	1,217,316
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-20,688	2,511,374	-0.82	25.19	-521,089	63,256,488
2018-09-14	2018-09-12	4	CDLX	Cardlytics, Inc. Common Stock	S - Sale		-75,805	2,532,062	-2.91	24.67	-1,870,109	62,465,970
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	M - Exercise		-641	0	-100.00
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	M - Exercise		-438	0	-100.00
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	M - Exercise		-1,247	0	-100.00
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	M - Exercise		-64,038	0	-100.00
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Common Stock	M - Exercise		641	26,076	2.52	0.00	0	10
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Common Stock	M - Exercise		438	17,860	2.51	0.00	0	7
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Common Stock	M - Exercise		1,247	50,823	2.52	0.00	0	20
2018-08-09	2018-08-09	4	CDLX	Cardlytics, Inc. Common Stock	M - Exercise		64,038	2,607,867	2.52	0.00	26	1,043
2018-08-09	2018-08-07	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	A - Award		641	641
2018-08-09	2018-08-07	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	A - Award		438	438
2018-08-09	2018-08-07	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	A - Award		1,247	1,247
2018-08-09	2018-08-07	4	CDLX	Cardlytics, Inc. Warrant (Right to Buy)	A - Award		64,038	64,038
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series A Warrant (right to buy)	P - Purchase		7,700	7,700
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series B Warrant (right to buy)	P - Purchase		7,700	7,700
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series A Warrant (right to buy)	P - Purchase		5,275	5,275
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series B Warrant (right to buy)	P - Purchase		5,275	5,275
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series A Warrant (right to buy)	P - Purchase		15,007	15,007
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series B Warrant (right to buy)	P - Purchase		15,007	15,007
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series A Warrant (right to buy)	P - Purchase		769,989	769,989
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series B Warrant (right to buy)	P - Purchase		769,989	769,989
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series A Warrant (right to buy)	P - Purchase		6,478	6,478
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series B Warrant (right to buy)	P - Purchase		6,478	6,478
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series A Warrant (right to buy)	P - Purchase		345,551	345,551
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Series B Warrant (right to buy)	P - Purchase		345,551	345,551
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		7,700	34,587	28.64
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		5,275	23,875	28.36
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		15,007	67,729	28.46
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		769,989	3,468,190	28.54
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		6,478	29,178	28.54
2018-04-05	2018-04-03	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		345,551	1,556,676	28.53
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G? Redeemable Convertible Preferred Stock	C - Conversion		-2,050	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G? Redeemable Convertible Preferred Stock	C - Conversion		-1,404	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G? Redeemable Convertible Preferred Stock	C - Conversion		-3,995	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G? Redeemable Convertible Preferred Stock	C - Conversion		-205,020	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G Redeemable Convertible Preferred Stock	C - Conversion		-280	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G Redeemable Convertible Preferred Stock	C - Conversion		-191	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G Redeemable Convertible Preferred Stock	C - Conversion		-545	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series G Redeemable Convertible Preferred Stock	C - Conversion		-27,988	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series E-R Redeemable Convertible Preferred Stock	C - Conversion		-255	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series E-R Redeemable Convertible Preferred Stock	C - Conversion		-175	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series E-R Redeemable Convertible Preferred Stock	C - Conversion		-498	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series E-R Redeemable Convertible Preferred Stock	C - Conversion		-25,571	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series D-R Redeemable Convertible Preferred Stock	C - Conversion		-1,644	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series D-R Redeemable Convertible Preferred Stock	C - Conversion		-1,126	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series D-R Redeemable Convertible Preferred Stock	C - Conversion		-3,205	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series D-R Redeemable Convertible Preferred Stock	C - Conversion		-164,446	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series C-R Redeemable Convertible Preferred Stock	C - Conversion		-4,176	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series C-R Redeemable Convertible Preferred Stock	C - Conversion		-2,861	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series C-R Redeemable Convertible Preferred Stock	C - Conversion		-8,140	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series C-R Redeemable Convertible Preferred Stock	C - Conversion		-417,683	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series B-R Redeemable Convertible Preferred Stock	C - Conversion		-9,311	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series B-R Redeemable Convertible Preferred Stock	C - Conversion		-6,378	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series B-R Redeemable Convertible Preferred Stock	C - Conversion		-18,148	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series B-R Redeemable Convertible Preferred Stock	C - Conversion		-931,174	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series A-R Redeemable Convertible Preferred Stock	C - Conversion		-7,719	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series A-R Redeemable Convertible Preferred Stock	C - Conversion		-5,287	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series A-R Redeemable Convertible Preferred Stock	C - Conversion		-15,045	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Series A-R Redeemable Convertible Preferred Stock	C - Conversion		-771,947	0	-100.00
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		2,050	25,435	8.77
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		1,404	17,422	8.77
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		3,995	49,576	8.76
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		205,020	2,543,829	8.77
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		280	23,385	1.21
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		191	16,018	1.21
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		545	45,581	1.21
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		27,988	2,338,809	1.21
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		255	23,105	1.12
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		175	15,827	1.12
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		498	45,036	1.12
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		25,571	2,310,821	1.12
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		1,644	22,850	7.75
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		1,126	15,652	7.75
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		3,205	44,538	7.75
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		164,446	2,285,250	7.75
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		4,176	21,206	24.52
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		2,861	14,526	24.53
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		8,140	41,333	24.52
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		417,683	2,120,804	24.52
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		9,311	17,030	120.62
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		6,378	11,665	120.64
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		18,148	33,193	120.62
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		931,174	1,703,121	120.63
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		7,719	7,719
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		5,287	5,287
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		15,045	15,045
2018-02-15	2018-02-13	4	CDLX	Cardlytics, Inc. Common Stock	C - Conversion		771,947	771,947
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series D Convertible Preferred Stock	C - Conversion		-21,537	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series D Convertible Preferred Stock	C - Conversion		-14,752	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series D Convertible Preferred Stock	C - Conversion		-41,976	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series D Convertible Preferred Stock	C - Conversion		-2,153,746	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series C Convertible Preferred Stock	C - Conversion		-2,213	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series C Convertible Preferred Stock	C - Conversion		-1,516	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series C Convertible Preferred Stock	C - Conversion		-4,315	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series C Convertible Preferred Stock	C - Conversion		-221,638	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series B Convertible Preferred Stock	C - Conversion		-7,108	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series B Convertible Preferred Stock	C - Conversion		-4,869	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series B Convertible Preferred Stock	C - Conversion		-13,854	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series B Convertible Preferred Stock	C - Conversion		-710,817	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-6,801	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-4,659	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-13,256	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-680,130	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-643	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-441	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-1,254	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-64,329	0	-100.00
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	P - Purchase		4,825	18,031	36.54	10.00	48,250	180,310
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	P - Purchase		3,305	12,351	36.54	10.00	33,050	123,510
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	P - Purchase		9,403	35,146	36.53	10.00	94,030	351,460
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	P - Purchase		482,467	1,803,429	36.52	10.00	4,824,670	18,034,290
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		6,310	13,206	91.50
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		4,322	9,046	91.49
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		12,298	25,743	91.47
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		631,041	1,320,962	91.47
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		1,102	6,896	19.02
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		755	4,724	19.02
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		2,150	13,445	19.03
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		110,312	689,921	19.03
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		3,173	5,794	121.06
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		2,173	3,969	120.99
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		6,185	11,295	121.04
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		317,376	579,609	121.03
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		2,433	2,621	1,294.15
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		1,667	1,796	1,292.25
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		4,743	5,110	1,292.37
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		243,385	262,233	1,291.30
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		188	188
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		129	129
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		367	367
2017-11-20	2017-11-20	4	ASNS	Arsanis, Inc. Common Stock	C - Conversion		18,848	18,848
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series E Convertible Preferred Stock	C - Conversion		-157,957	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series E Convertible Preferred Stock	C - Conversion		-1,579	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series E Convertible Preferred Stock	C - Conversion		-1,082	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series E Convertible Preferred Stock	C - Conversion		-3,078	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series D Convertible Preferred Stock	C - Conversion		-238,470	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series D Convertible Preferred Stock	C - Conversion		-2,384	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series D Convertible Preferred Stock	C - Conversion		-1,632	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series D Convertible Preferred Stock	C - Conversion		-4,647	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series C Convertible Preferred Stock	C - Conversion		-226,801	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series C Convertible Preferred Stock	C - Conversion		-2,267	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series C Convertible Preferred Stock	C - Conversion		-1,553	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series C Convertible Preferred Stock	C - Conversion		-4,420	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series B Convertible Preferred Stock	C - Conversion		-609,316	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series B Convertible Preferred Stock	C - Conversion		-6,093	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series B Convertible Preferred Stock	C - Conversion		-4,174	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series B Convertible Preferred Stock	C - Conversion		-11,875	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series A Convertible Preferred Stock	C - Conversion		-333,207	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series A Convertible Preferred Stock	C - Conversion		-3,332	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series A Convertible Preferred Stock	C - Conversion		-2,282	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Series A Convertible Preferred Stock	C - Conversion		-6,494	0	-100.00
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	P - Purchase		144,740	1,836,703	8.55	14.00	2,026,360	25,713,842
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	P - Purchase		1,448	18,364	8.56	14.00	20,272	257,096
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	P - Purchase		991	12,577	8.55	14.00	13,874	176,078
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	P - Purchase		2,821	35,793	8.56	14.00	39,494	501,102
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	C - Conversion		1,652,646	1,691,963	4,203.39
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	C - Conversion		16,524	16,916	4,215.31
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	C - Conversion		11,318	11,586	4,223.13
2016-06-29	2016-06-27	4	SELB	SELECTA BIOSCIENCES INC Common Stock	C - Conversion		32,207	32,972	4,210.07
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,507
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,010
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,134
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				80,059
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,507
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,010
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,134
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				80,059
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,507
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,010
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,134
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				80,059
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,507
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,010
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,134
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				80,059
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,507
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,010
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,134
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				80,059
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,507
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,010
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				41,134
2016-06-21		3	SELB	SELECTA BIOSCIENCES INC Common Stock				80,059
2015-08-07	2015-08-05	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-10,367	2,030,917	-0.51	15.02	-155,713	30,504,576
2015-08-07	2015-08-05	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-104	79,844	-0.13	15.02	-1,562	1,199,265
2015-08-07	2015-08-05	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-71	58,001	-0.12	15.02	-1,066	871,181
2015-08-07	2015-08-05	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-202	37,961	-0.53	15.02	-3,034	570,178
2015-07-24	2015-07-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-385	2,041,284	-0.02	15.00	-5,775	30,619,260
2015-07-24	2015-07-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-4	79,948	-0.01	15.00	-60	1,199,220
2015-07-24	2015-07-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-3	58,072	-0.01	15.00	-45	871,080
2015-07-24	2015-07-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-8	38,163	-0.02	15.00	-120	572,445
2015-07-24	2015-07-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,041,669	-0.70	15.04	-217,727	30,712,010
2015-07-24	2015-07-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	79,952	-0.18	15.04	-2,166	1,202,686
2015-07-24	2015-07-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,075	-0.17	15.04	-1,489	873,599
2015-07-24	2015-07-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	38,171	-0.73	15.04	-4,242	574,191
2015-07-22	2015-07-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,056,143	-0.70	15.22	-220,357	31,303,338
2015-07-22	2015-07-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,096	-0.18	15.22	-2,192	1,219,406
2015-07-22	2015-07-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,174	-0.17	15.22	-1,507	885,658
2015-07-22	2015-07-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	38,453	-0.73	15.22	-4,293	585,420
2015-07-22	2015-07-21	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,070,617	-0.69	15.42	-223,202	31,930,778
2015-07-22	2015-07-21	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,240	-0.18	15.42	-2,221	1,237,373
2015-07-22	2015-07-21	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,273	-0.17	15.42	-1,527	898,622
2015-07-22	2015-07-21	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	38,735	-0.72	15.42	-4,349	597,329
2015-07-22	2015-07-20	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,085,091	-0.69	16.05	-232,340	33,470,298
2015-07-22	2015-07-20	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,384	-0.18	16.05	-2,312	1,290,340
2015-07-22	2015-07-20	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,372	-0.17	16.05	-1,589	936,999
2015-07-22	2015-07-20	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	39,017	-0.72	16.05	-4,527	626,309
2015-07-17	2015-07-17	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,099,565	-0.68	16.30	-235,894	34,218,290
2015-07-17	2015-07-17	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,528	-0.18	16.30	-2,347	1,312,429
2015-07-17	2015-07-17	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,471	-0.17	16.30	-1,613	952,949
2015-07-17	2015-07-17	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	39,299	-0.71	16.30	-4,596	640,487
2015-07-17	2015-07-16	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,114,039	-0.68	16.33	-236,384	34,525,639
2015-07-17	2015-07-16	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,672	-0.18	16.33	-2,352	1,317,503
2015-07-17	2015-07-16	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,570	-0.17	16.33	-1,617	956,542
2015-07-17	2015-07-16	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	39,581	-0.71	16.33	-4,606	646,421
2015-07-17	2015-07-15	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,128,513	-0.68	16.14	-233,664	34,362,075
2015-07-17	2015-07-15	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,816	-0.18	16.14	-2,325	1,304,669
2015-07-17	2015-07-15	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,669	-0.17	16.14	-1,598	947,135
2015-07-17	2015-07-15	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	39,863	-0.70	16.14	-4,553	643,536
2015-07-14	2015-07-14	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,142,987	-0.67	16.54	-239,419	35,447,791
2015-07-14	2015-07-14	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	80,960	-0.18	16.54	-2,382	1,339,184
2015-07-14	2015-07-14	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,768	-0.17	16.54	-1,638	972,099
2015-07-14	2015-07-14	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	40,145	-0.70	16.54	-4,665	664,050
2015-07-14	2015-07-13	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,157,461	-0.67	16.60	-240,206	35,804,576
2015-07-14	2015-07-13	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,104	-0.18	16.60	-2,390	1,345,978
2015-07-14	2015-07-13	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,867	-0.17	16.60	-1,643	976,939
2015-07-14	2015-07-13	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	40,427	-0.69	16.60	-4,680	670,914
2015-07-10	2015-07-10	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,171,935	-0.66	16.63	-240,637	36,109,505
2015-07-10	2015-07-10	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,248	-0.18	16.63	-2,394	1,350,789
2015-07-10	2015-07-10	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	58,966	-0.17	16.63	-1,646	980,339
2015-07-10	2015-07-10	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	40,709	-0.69	16.63	-4,688	676,807
2015-07-10	2015-07-09	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,186,409	-0.66	16.12	-233,377	35,253,440
2015-07-10	2015-07-09	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,392	-0.18	16.12	-2,322	1,312,356
2015-07-10	2015-07-09	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,065	-0.17	16.12	-1,596	952,358
2015-07-10	2015-07-09	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	40,991	-0.68	16.12	-4,547	660,935
2015-07-10	2015-07-08	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,200,883	-0.65	15.99	-231,510	35,202,903
2015-07-10	2015-07-08	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,536	-0.18	15.99	-2,303	1,304,160
2015-07-10	2015-07-08	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,164	-0.17	15.99	-1,583	946,322
2015-07-10	2015-07-08	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	41,273	-0.68	15.99	-4,511	660,158
2015-07-07	2015-07-07	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,215,357	-0.65	16.23	-234,913	35,955,244
2015-07-07	2015-07-07	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,680	-0.18	16.23	-2,337	1,325,666
2015-07-07	2015-07-07	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,263	-0.17	16.23	-1,607	961,838
2015-07-07	2015-07-07	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	41,555	-0.67	16.23	-4,577	674,438
2015-07-07	2015-07-06	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,229,831	-0.64	15.98	-231,305	35,634,260
2015-07-07	2015-07-06	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,824	-0.18	15.98	-2,301	1,307,605
2015-07-07	2015-07-06	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,362	-0.17	15.98	-1,582	948,646
2015-07-07	2015-07-06	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	41,837	-0.67	15.98	-4,507	668,585
2015-07-07	2015-07-02	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,244,305	-0.64	15.51	-224,424	34,798,622
2015-07-07	2015-07-02	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	81,968	-0.18	15.51	-2,233	1,270,938
2015-07-07	2015-07-02	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,461	-0.17	15.51	-1,535	921,961
2015-07-07	2015-07-02	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	42,119	-0.67	15.51	-4,372	653,068
2015-07-01	2015-07-01	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,258,779	-0.64	15.77	-228,296	35,627,269
2015-07-01	2015-07-01	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,112	-0.18	15.77	-2,271	1,295,136
2015-07-01	2015-07-01	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,560	-0.17	15.77	-1,562	939,428
2015-07-01	2015-07-01	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	42,401	-0.66	15.77	-4,448	668,782
2015-07-01	2015-06-30	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,273,253	-0.63	16.22	-234,706	36,862,389
2015-07-01	2015-06-30	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,256	-0.17	16.22	-2,335	1,333,839
2015-07-01	2015-06-30	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,659	-0.17	16.22	-1,605	967,412
2015-07-01	2015-06-30	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	42,683	-0.66	16.22	-4,573	692,135
2015-07-01	2015-06-29	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,287,727	-0.63	16.28	-235,590	37,236,875
2015-07-01	2015-06-29	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,400	-0.17	16.28	-2,344	1,341,208
2015-07-01	2015-06-29	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,758	-0.17	16.28	-1,611	972,669
2015-07-01	2015-06-29	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	42,965	-0.65	16.28	-4,590	699,333
2015-06-26	2015-06-26	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,302,201	-0.62	16.76	-242,594	38,586,500
2015-06-26	2015-06-26	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,544	-0.17	16.76	-2,414	1,383,495
2015-06-26	2015-06-26	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,857	-0.17	16.76	-1,659	1,003,245
2015-06-26	2015-06-26	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	43,247	-0.65	16.76	-4,727	724,850
2015-06-26	2015-06-25	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,316,675	-0.62	16.85	-243,932	39,043,155
2015-06-26	2015-06-25	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,688	-0.17	16.85	-2,427	1,393,549
2015-06-26	2015-06-25	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	59,956	-0.16	16.85	-1,668	1,010,444
2015-06-26	2015-06-25	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	43,529	-0.64	16.85	-4,753	733,599
2015-06-26	2015-06-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,331,149	-0.62	17.61	-254,929	41,058,294
2015-06-26	2015-06-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,832	-0.17	17.61	-2,536	1,458,912
2015-06-26	2015-06-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	60,055	-0.16	17.61	-1,744	1,057,743
2015-06-26	2015-06-24	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	43,811	-0.64	17.61	-4,967	771,639
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		15,264	15,264
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		7,832	7,832
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		5,365	5,365
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		783,128	783,128
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		6,589	6,589
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		351,448	351,448
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		1,392	52,722	2.71	6.88	9,570	362,464
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		715	26,887	2.73	6.88	4,916	184,848
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		490	18,600	2.71	6.88	3,369	127,875
2015-06-25	2015-06-15	4/A	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		71,439	2,698,201	2.72	6.88	491,143	18,550,132
2015-06-24	2015-06-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,345,623	-0.61	18.15	-262,664	42,566,724
2015-06-24	2015-06-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	82,976	-0.17	18.15	-2,613	1,505,790
2015-06-24	2015-06-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	60,154	-0.16	18.15	-1,797	1,091,633
2015-06-24	2015-06-23	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	44,093	-0.64	18.15	-5,118	800,169
2015-06-24	2015-06-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-14,474	2,360,097	-0.61	18.22	-263,671	42,993,651
2015-06-24	2015-06-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-144	83,120	-0.17	18.22	-2,623	1,514,189
2015-06-24	2015-06-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-99	60,253	-0.16	18.22	-1,803	1,097,623
2015-06-24	2015-06-22	4	TTOO	T2 Biosystems, Inc. Common Stock	S - Sale	X	-282	44,375	-0.63	18.22	-5,137	808,375
2015-06-19	2015-06-19	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-1,000	1,968,606	-0.05	13.00	-13,000	25,591,878
2015-06-19	2015-06-18	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-29,004	1,969,606	-1.45	13.04	-378,212	25,683,662
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Stock Option (Right to Buy)	A - Award		17,710	17,710
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		15,264	15,264
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		7,832	7,832
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		5,365	5,365
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		783,128	783,128
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		6,589	6,589
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Warrants to Purchase Common Stock	A - Award		351,448	351,448
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		1,392	52,692	2.71	6.88	9,570	362,258
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	A - Award		51,330	51,330
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		714	26,886	2.73	6.88	4,909	184,841
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	A - Award		26,172	26,172
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		489	18,599	2.70	6.88	3,362	127,868
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	A - Award		18,110	18,110
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		71,438	2,698,200	2.72	6.88	491,136	18,550,125
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	A - Award		2,626,762	2,626,762
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		601	22,700	2.72	6.88	4,132	156,062
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	A - Award		22,099	22,099
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	P - Purchase		32,059	1,211,125	2.72	6.88	220,406	8,326,484
2015-06-17	2015-06-15	4	PULM	Pulmatrix, Inc. Common Stock	A - Award		1,179,066	1,179,066
2015-06-17	2015-06-17	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-10,618	1,998,610	-0.53	13.01	-138,140	26,001,916
2015-06-17	2015-06-16	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-46,000	2,009,228	-2.24	13.24	-609,040	26,602,179
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series E Redeemable Convertible Preferred Stock	C - Conversion		-8,623	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series E Redeemable Convertible Preferred Stock	C - Conversion		-5,906	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series E Redeemable Convertible Preferred Stock	C - Conversion		-16,806	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series E Redeemable Convertible Preferred Stock	C - Conversion		-862,318	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series D Redeemable Convertible Preferred Stock	C - Conversion		-14,706	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series D Redeemable Convertible Preferred Stock	C - Conversion		-10,074	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series D Redeemable Convertible Preferred Stock	C - Conversion		-28,661	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series D Redeemable Convertible Preferred Stock	C - Conversion		-1,470,577	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series C Redeemable Convertible Preferred Stock	C - Conversion		-42,087	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series C Redeemable Convertible Preferred Stock	C - Conversion		-28,831	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series C Redeemable Convertible Preferred Stock	C - Conversion		-82,029	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series C Redeemable Convertible Preferred Stock	C - Conversion		-4,208,756	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B-2 Redeemable Convertible Preferred Stock	C - Conversion		-41,686	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B-2 Redeemable Convertible Preferred Stock	C - Conversion		-28,556	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B-2 Redeemable Convertible Preferred Stock	C - Conversion		-81,248	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B-2 Redeemable Convertible Preferred Stock	C - Conversion		-4,168,683	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B Redeemable Convertible Preferred Stock	C - Conversion		-34,737	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B Redeemable Convertible Preferred Stock	C - Conversion		-23,796	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B Redeemable Convertible Preferred Stock	C - Conversion		-67,704	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Series B Redeemable Convertible Preferred Stock	C - Conversion		-3,473,763	0	-100.00
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		890	17,638	5.31
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		610	12,082	5.32
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		1,736	34,378	5.32
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		89,069	1,763,894	5.32
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		16,748	16,748
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		11,472	11,472
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		32,642	32,642
2015-05-14	2015-05-12	4	LIFE	aTYR PHARMA INC Common Stock	C - Conversion		1,674,825	1,674,825
2015-02-04	2015-02-02	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	S - Sale		-4,824	19,588	-19.76	29.50	-142,308	577,846
2015-02-04	2015-02-02	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	S - Sale		-3,304	13,419	-19.76	29.50	-97,468	395,860
2015-02-04	2015-02-02	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	S - Sale		-9,403	38,178	-19.76	29.50	-277,388	1,126,251
2015-02-04	2015-02-02	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	S - Sale		-482,469	1,958,824	-19.76	29.50	-14,232,836	57,785,308
2014-08-18	2014-08-14	4	TRVN	TREVENA INC Common Stock	S - Sale		-354	36,369	-0.96	6.04	-2,138	219,669
2014-08-18	2014-08-14	4	TRVN	TREVENA INC Common Stock	S - Sale		-243	24,911	-0.97	6.04	-1,468	150,462
2014-08-18	2014-08-14	4	TRVN	TREVENA INC Common Stock	S - Sale		-690	70,885	-0.96	6.04	-4,168	428,145
2014-08-18	2014-08-14	4	TRVN	TREVENA INC Common Stock	S - Sale		-35,415	3,637,115	-0.96	6.04	-213,907	21,968,175
2014-08-15	2014-08-14	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-6,755	2,055,228	-0.33	13.01	-87,883	26,738,516
2014-08-15	2014-08-13	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-2,905	2,061,983	-0.14	13.00	-37,765	26,805,779
2014-08-15	2014-08-13	4	TRVN	TREVENA INC Common Stock	S - Sale		-55	36,723	-0.15	6.12	-337	224,745
2014-08-15	2014-08-13	4	TRVN	TREVENA INC Common Stock	S - Sale		-38	25,154	-0.15	6.12	-233	153,942
2014-08-15	2014-08-13	4	TRVN	TREVENA INC Common Stock	S - Sale		-107	71,575	-0.15	6.12	-655	438,039
2014-08-15	2014-08-13	4	TRVN	TREVENA INC Common Stock	S - Sale		-5,500	3,672,530	-0.15	6.12	-33,660	22,475,884
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Series E Convertible Preferred Stock	C - Conversion		-631,133	0	-100.00
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Series D Convertible Preferred Stock	C - Conversion		-629,852	0	-100.00
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Series C Convertible Preferred Stock	C - Conversion		-819,493	0	-100.00
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Series B Convertible Preferred Stock	C - Conversion		-1,053,201	0	-100.00
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Series A-2 Convertible Preferred Stock	C - Conversion		-774,527	0	-100.00
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Series A-1 Convertible Preferred Stock	C - Conversion		-128,567	0	-100.00
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Common Stock	C - Conversion		2,291,307	2,374,571	2,751.86
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Common Stock	C - Conversion		22,912	83,264	37.96
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Common Stock	C - Conversion		15,695	60,352	35.15
2014-08-14	2014-08-12	4	TTOO	T2 Biosystems, Inc. Common Stock	C - Conversion		44,657	44,657
2014-08-12	2014-08-12	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-20,990	2,064,888	-1.01	13.03	-273,500	26,905,491
2014-08-12	2014-08-11	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-1,428	2,085,878	-0.07	13.24	-18,907	27,617,025
2014-08-12	2014-08-08	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	S - Sale		-41,376	2,087,306	-1.94	13.41	-554,852	27,990,773
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series D Preferred Stock	C - Conversion		-24,181	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series D Preferred Stock	C - Conversion		-16,565	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series D Preferred Stock	C - Conversion		-47,131	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series D Preferred Stock	C - Conversion		-2,418,191	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series C Preferred Stock	C - Conversion		-40,268	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series C Preferred Stock	C - Conversion		-27,584	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series C Preferred Stock	C - Conversion		-78,483	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Series C Preferred Stock	C - Conversion		-4,026,825	0	-100.00
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		9,159	24,412	60.05
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		6,275	16,723	60.06
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		17,853	47,581	60.05
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		915,981	2,441,293	60.05
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		15,253	15,253
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		10,448	10,448
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		29,728	29,728
2014-07-31	2014-07-30	4	OCUL	OCULAR THERAPEUTIX, INC Common Stock	C - Conversion		1,525,312	1,525,312
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Warrant to purchase Common Stock	J - Other		25,092	25,092
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Warrant to purchase Series C	J - Other			0
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Series B-1 Convertible Preferred Stock	C - Conversion		-6,793,234	0	-100.00
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. 7% Convertible Promissory Notes	C - Conversion			0
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. 7% Convertible Promissory Notes	C - Conversion		-2,698,039	0	-100.00
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Series D Convertible Preferred Stock	C - Conversion		-5,513,524	0	-100.00
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Series C Convertible Preferred Stock	C - Conversion		-2,278,494	0	-100.00
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Common Stock	P - Purchase		1,470,582	3,262,437	82.07	7.00	10,294,074	22,837,059
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Common Stock	C - Conversion		401,061	1,791,855	28.84
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Common Stock	C - Conversion		385,435	1,390,794	38.34
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Common Stock	C - Conversion		380,044	1,005,359	60.78
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Common Stock	C - Conversion		157,052	625,315	33.54
2014-04-15	2014-04-15	4	CERU	Cerulean Pharma Inc. Common Stock	C - Conversion		468,263	468,263
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Warrants to purchase Series A Preferred Stock	X - Other		-399,909	0	-100.00
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Series C Preferred Stock	C - Conversion		-6,075,152	0	-100.00
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Series B Preferred Stock	C - Conversion		-5,836,663	0	-100.00
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Series A Preferred Stock	C - Conversion		-8,393,754	0	-100.00
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Seed Preferred Stock	C - Conversion		-2,126,923	0	-100.00
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	P - Purchase		232,820	2,128,678	12.28	12.00	2,793,840	25,544,136
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	C - Conversion		10,781	1,895,858	0.57
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	C - Conversion		510,516	1,885,077	37.14
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	C - Conversion		490,474	1,374,561	55.48
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	C - Conversion		705,356	884,087	394.65
2014-02-11	2014-02-10	4	GNCA	GENOCEA BIOSCIENCES, INC. Common Stock	C - Conversion		178,731	178,731
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Series C Preferred Stock	C - Conversion		-4,840,686	0	-100.00
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Series B-1 Preferred Stock	C - Conversion		-1,462,868	0	-100.00
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Series B-1 Preferred Stock	S - Sale		-487,132	62,868	-88.57	1.13	-549,972	70,978
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Series B-1 Preferred Stock	X - Other		550,000	550,000		1.00	550,000	550,000
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Warrants- Purchase Series B-1 Preferred Stock (right to buy)	X - Other		-550,000	0	-100.00
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Series B Preferred Stock	C - Conversion		-8,400,000	0	-100.00
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Series A Preferred Stock	C - Conversion		-6,000,000	0	-100.00
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Common Stock	P - Purchase		472,405	3,811,682	14.15	7.00	3,306,835	26,681,774
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Common Stock	C - Conversion		780,754	3,339,277	30.52
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Common Stock	C - Conversion		235,946	2,558,523	10.16
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Common Stock	C - Conversion		1,354,837	2,322,577	140.00
2014-02-07	2014-02-05	4	TRVN	TREVENA INC Common Stock	C - Conversion		967,740	967,740
2014-01-30		3	TRVN	TREVENA INC Common Stock				0
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-5,506	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-5,506	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-3,772	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-3,772	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-10,732	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-10,732	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-550,653	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series C Convertible Preferred Stock	C - Conversion		-550,653	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series B Convertible Preferred Stock	C - Conversion		-2,227	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series B Convertible Preferred Stock	C - Conversion		-2,227	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series B Convertible Preferred Stock	C - Conversion		-1,525	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series B Convertible Preferred Stock	C - Conversion		-1,525	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series B Convertible Preferred Stock	C - Conversion		-4,340	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series B Convertible Preferred Stock	C - Conversion		-222,677	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series A Convertible Preferred Stock	C - Conversion		-6,518	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series A Convertible Preferred Stock	C - Conversion		-4,465	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series A Convertible Preferred Stock	C - Conversion		-12,704	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Series A Convertible Preferred Stock	C - Conversion		-651,806	0	-100.00
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	P - Purchase		8,041	2,473,186	0.33	6.00	48,246	14,839,116
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	P - Purchase		5,508	2,465,145	0.22	6.00	33,048	14,790,870
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	P - Purchase		15,672	2,459,637	0.64	6.00	94,032	14,757,822
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	P - Purchase		804,112	2,443,965	49.04	6.00	4,824,672	14,663,790
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	J - Other		1,239	1,639,853	0.08	6.00	7,434	9,839,118
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	J - Other		849	1,638,614	0.05	6.00	5,094	9,831,684
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	J - Other		2,415	1,637,765	0.15	6.00	14,490	9,826,590
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	J - Other		123,943	1,635,350	8.20	6.00	743,658	9,812,100
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		2,560	1,511,407	0.17
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		12,024	1,508,847	0.80
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		1,753	1,496,823	0.12
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		8,237	1,495,070	0.55
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		4,988	1,486,833	0.34
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		23,436	1,481,845	1.61
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		255,950	1,458,409	21.29
2013-10-07	2013-10-04	4	FATE	FATE THERAPEUTICS INC Common Stock	C - Conversion		1,202,459	1,202,459
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Series D Preferred Stock	C - Conversion		-964,798	0	-100.00
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Series C-1 Preferred Stock	C - Conversion		-390,170	0	-100.00
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Series C Preferred Stock	C - Conversion		-487,780	0	-100.00
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Series B Preferred Stock	C - Conversion		-1,900,000	0	-100.00
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Series A Preferred Stock	C - Conversion		-1,476,960	0	-100.00
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Common Stock	P - Purchase		26,000	2,018,253	1.31	15.00	390,000	30,273,795
2013-09-27	2013-09-25	4	BIND	BIND Therapeutics, Inc Common Stock	C - Conversion		1,992,253	1,992,253

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)